MedTrace Logo

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

NCT02418442 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2025-10-14

No results posted yet for this study

Summary

Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

Conditions

  • Rheumatic Joint Disease

Sponsors & Collaborators

  • Childhood Arthritis and Rheumatology Research Alliance

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Mara L Becker, MD, MSCE · Duke Clinical Research Insitute

  • Mary Beth Son, MD · Boston Children's Hospital

  • Timothy Beukelman, MD, MSCE · University of Alabama at Birmingham

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2028-06-30
Completion
2028-12-31

Countries

  • United States
  • Canada
  • Israel
  • Italy
  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02418442 on ClinicalTrials.gov